Trial intelligence / Profile preview

CombiflexOmega peri vs SmofKabiven peripheral in postoperative PN

NCT01533298Phase 3Completed

Sponsor
JW Life Science
Start
Jul 2011
Primary completion
Dec 2011
Modality
PN (Parenteral nutrition solution)
Countries
1
01

Overview

A Phase 3 trial of CombiflexOmega peri in Malnutrition, Post-operative care, sponsored by JW Life Science. Started Jul 2011; status: completed.

02

Drugs

CombiflexOmega peri
03

Conditions

MalnutritionPost-operative care

Beyond the preview

Go deeper on NCT01533298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01533298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call